Martingale Asset Management L P Kezar Life Sciences, Inc. Transaction History

Martingale Asset Management L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.13 - $7.31 $105,665 - $246,778	-33,759 Reduced 60.31%	22,220 $69,000
Q4 2022 Feb 13, 2023	BUY	$6.39 - $8.8 $357,705 - $492,615	55,979 New	55,979 $394,000
Q4 2021 Feb 11, 2022	SELL	$7.44 - $16.72 $194,325 - $436,709	-26,119 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.85 - $9.73 $126,677 - $254,137	26,119 New	26,119 $225,000
Q4 2020 Feb 10, 2021	SELL	$4.77 - $6.58 $263,866 - $363,992	-55,318 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$4.36 - $5.5 $417,252 - $526,350	-95,700 Reduced 63.37%	55,318 $267,000
Q2 2020 Aug 10, 2020	BUY	$3.6 - $7.75 $543,664 - $1.17 Million	151,018 New	151,018 $782,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.